Home
BAJAJHCARE.NS

Bajaj HealthCare Limited

NSEHealthcare
₹345.00
+0.77%+₹2.65 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹342.35
Day range
₹0 – ₹0
52W range
₹272.35 – ₹552.6
Volume
1.5L
Avg vol (20D)
10.5L
Mkt cap
₹1,160.02Cr
P/E TTM
51.1×

Trade Bajaj HealthCare Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹611.03 Cr
Net Income (ttm)₹0.00
Shares Out3.37 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.18

About BAJAJHCARE.NS

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, phlebotropic drug, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolBAJAJHCARE.NS
BAJAJHCARE.NS · NSE
Financial Performance

In 2026, Bajaj HealthCare Limited's revenue was ₹611.03 Cr, an decrease of +0.90% compared to the previous year. Earnings were ₹0.00, an decrease of 0.00%.

Revenue (2026)
₹611.03 Cr
-0.90% YoY
Earnings (2026)
₹0.00
0.00% YoY
Year-over-Year Growth
Revenue
-0.90%
Earnings
0.00%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.